Takahiro Mimae

26PUBLICATIONS
44CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 24, 2026
Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

|Dec 25, 2025
Invited Editorial: Recurrence Risk Prediction in Lung Cancer.

Takahiro Mimae

|Nov 06, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.

Masahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji

|Oct 29, 2025
Visceral Pleural Invasion as a Determinant of Surgical Strategy in Non-Small Cell Lung Cancer: A Multicenter Study.

Wakako Nagase, Yujin Kudo, Takuya Nagashima

|Aug 13, 2025
Lymph node dissection as a local control during segmentectomy for small-sized and radiologically solid dominant and pure solid tumors.

Takahiro Mimae, Yoshihiro Miyata, Norifumi Tsubokawa

|Jun 22, 2025
Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non-small cell lung cancer in 80 or more aged elderly patients: a randomized phase III study (JCOG2109, AWESOME).

Takahiro Mimae, Masashi Wakabayashi, Yusuke Sano

Pageof 5

Frequent Collaborators

16 joint publications

Morihito Okada

11 joint publications

Yasuhiro Tsutani

9 joint publications

Norifumi Tsubokawa

8 joint publications

Hiroyuki Ito